Loading...

Loading...

Merck to Request Emergency Use Authorization for COVID-19 Pill
By Antonio Gozain - Fri, 10/01/2021 - 16:49
An interim analysis indicated that Merck’s molnupiravir halves the chances of dying or being hospitalized for severe COVID-19 illness.